In a research report released Friday, Cowen analyst Ritu Baral reiterated an Outperform rating on shares of Cytokinetics, Inc. (NASDAQ:CYTK) with a price target of …
McKesson Corporation McKesson Corporation (NYSE:MCK) shares are falling nearly 22% today after the company reported disappointing results for the fiscal second-quarter and issued lackluster guidance. MCK posted …
Today, Global Blood Therapeutics Inc (NASDAQ:GBT) announced design of the pivotal two-part GBT-440 Phase III HOPE trial in evaluating adults and adolescents with …
Valeant Pharmaceuticals Intl Inc Wells Fargo analyst David Maris is out today with another bearish note on Valeant Pharmaceuticals Intl Inc (NYSE:VRX). In this episode, …
Following bluebird bio Inc’s (NASDAQ:BLUE) first research and development (R&D) meeting, Cowen top analyst Eric Schmidt shares insight on the firm’s preclinical strides …
Cowen’s biotech team weighs in with upbeat perspectives on biotech firms Gilead Sciences, Inc. (NASDAQ:GILD), Exelixis Inc.
On Monday, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) presented updated clinical data from its ongoing Phase 1/2 trial on its investigational tyrosine kinase inhibitor, pipeline …
Cowen top analyst Ritu Baral shares insight on Sarepta Therapeutics Inc (NASDAQ:SRPT) after speaking with three key opinion leaders (KOLs) regarding the recent approval …
At the European Society for Medical Oncology (ESMO) conference, Incyte Corporation (NASDAQ:INCY) presented updated data from its Phase I trial of epacadostat and …
Cowen top analyst Ritu Baral chimes in on Cytokinetics, Inc. (NASDAQ:CYTK) after Amgen, Inc.
